-
Product Insights
MI MySolar Ltd (Gujarat Solar Policy – Phase I)
MI MySolar Ltd (Gujarat Solar Policy - Phase I) is a solar PV project located in Gujarat, India. The project is owned and developed by Walwhan Renewable Energy Ltd. The project came online in 2012. Empower your strategies with our MI MySolar Ltd (Gujarat Solar Policy - Phase I) report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of...
-
Product Insights
Spinal Fusion Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Spinal Fusion Pipeline Market Report Overview Spinal Fusion procedures are mainly performed on the cervical and thoracolumbar regions. Spinal fusion is a surgical procedure that involves joining two vertebrae in the spine to form a single solid bone, with the involvement of certain devices, to relieve pain. Conventional and Minimally Invasive Surgery (MIS) methods are used to perform Spinal Fusion. Conventional methods include all open surgical methods that are used for performing spinal procedures. The Spinal Fusion pipeline market research...
-
Product Insights
Transcatheter Mitral Valve Implantation (TMVI) Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Transcatheter Mitral Valve Implantation (TMVI) Pipeline Market Report Overview The transcatheter heart valve is an artificial heart valve made up of natural tissue surrounded by a flexible mesh frame known as stent. All the components are placed in a long narrow tube known as a catheter which is then inserted into a large blood vessel in the groin area or through a small incision in chest. The transcatheter mitral valve implantation (TMVI) pipeline market research report provides a comprehensive understanding...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FP-045 in Fanconi Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FP-045 in Fanconi Anemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FP-045 in Fanconi Anemia Drug Details: FP-045 is under development for...
-
Sector Analysis
Endoscopy Fluid Management Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Endoscopy Fluid Management Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within Endoscopy Devices therapeutic area. The model discusses in detail the impact of COVID-19 on Endoscopy Fluid Management Systems market for the year 2020 and beyond. Endoscopy Fluid Management Systems are used during Endoscopy examinations such as laparoscopy, hysteroscopy to enhance the visibility. The goal of these devices is to improve visibility by managing fluid near...
-
Product Insights
Minimally Invasive Surgical (MIS) Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
MIS Devices Pipeline Market Report Overview MIS is a term used to describe either a smaller incision (typically half of the length of the traditional incision) or an approach that does not involve cutting tendons or splitting muscles. MIS stands for Minimally invasive surgery. The MIS Devices pipeline market research report provides comprehensive information about the MIS devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are...
-
Sector Analysis
Robotic Surgical Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Robotic Surgical Systems Market Report Overview The robotic surgical systems market size was $2.84 billion in 2023. The market is expected to grow at a CAGR of more than 11% during 2023-2033. Robotic surgical systems are passive devices controlled by a surgeon and typically consist of a patient-side cart, a surgeon console, and a vision system. These devices are designed to work around the limitations that are still present in minimally invasive surgical (MIS) procedures by improving surgeon accuracy and...
-
Sector Analysis
Laparoscopic Access Instruments Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Laparoscopic Access Instruments Market Report Overview The laparoscopic access instruments market size was $1.04 billion in 2023. The market is expected to grow at a CAGR of more than 4% during 2023-2033. Laparoscopic access instruments are used during laparoscopic procedures for the placement of medical devices, such as graspers, scissors, and forceps. Laparoscopic access instruments are used in numerous minimally invasive surgical (MIS) procedures spanning multiple therapeutic areas and fields of expertise. Laparoscopic Access Instruments Market Outlook, 2023-2033 ($ Billion)...
-
Sector Analysis
Robotic Surgical System Accessories Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Robotic Surgical System Accessories Market Report Overview The robotic surgical system accessories market size was $5.43 billion in 2023. Factors such as improving technologies for robotic surgical systems, and value-based healthcare will drive the market growth at a CAGR of more than 2% during 2023-2033. Robotic surgical system accessories are designed to enhance surgeon accuracy in minimally invasive surgical procedures. They help facilitate difficult surgical procedures by working around the limitations present in MIS. Robotic Surgical System Accessories Market Outlook,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Golocdacimab in Myocardial Infarction
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Golocdacimab in Myocardial Infarction report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Golocdacimab in Myocardial Infarction Drug Details: Golocdacimab (MEDI-6570) is under development for...